US EditionPublished • loading... • Updated
RCKT Investors Have Opportunity to Lead Rocket Pharmaceuticals, Inc. Securities Fraud Lawsuit
NEW YORK, UNITED STATES, JUN 12 – The Rosen Law Firm invites investors with significant losses in Rocket Pharmaceuticals, Inc. to join the class action lawsuit as lead plaintiffs before the August deadline.
- On 2025-07-27, Rosen Law Firm reminded investors of the Class Period from February 27, 2025 to May 26, 2025 and the August 11, 2025 lead plaintiff deadline.
- With hundreds of millions recovered, Rosen Law Firm is a global investor-rights law firm ranked among the top four since 2013.
- According to the lawsuit, defendants concealed SAE risks and amended the protocol without disclosure.
- Rosen Law Firm has filed a class action, and investors may claim compensation without out-of-pocket fees.
- Prospective lead plaintiffs must move by August 11, 2025, Rosen Law Firm says, and until class certification, claimants lack representation unless they retain counsel.
Insights by Ground AI
143 Articles
143 Articles
RECKITT BENCKISER SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Reckitt Benckiser Group PLC
NEW ORLEANS, June 13, 2025 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 4, 2025 to file lead plaintiff applications in a securities class action lawsuit against Reckitt Benckiser Group PLC ("Reckitt" or…
PR NewswireReposted by 
CNHI News
CNHI NewsRCKT INVESTOR ALERT: Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead the Rocket Pharmaceuticals Class Action Lawsuit
/PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) securities between...
·United States
Read Full Article
Rocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class Action Amid Protocol Change and FDA’s Clinical Hold on Gene Therapy Trial – Hagens Berman
SAN FRANCISCO, June 12, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit styled Ho v. Rocket Pharmaceuticals, Inc., et al., No. 3:25-cv-10049...
Coverage Details
Total News Sources143
Leaning Left18Leaning Right10Center48Last UpdatedBias Distribution63% Center
Bias Distribution
- 63% of the sources are Center
63% Center
L 24%
C 63%
13%
Factuality
To view factuality data please Upgrade to Premium
